Clinical Trial

The Oxford Risk Factors And Non-Invasive Imaging Study

Study acronym: ORFAN
Recruiting
View on ClinicalTrials.gov →
Summary
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Protocol Amendment History 1 change
notable Trial sites expanded: 37 -> 45 locations 2026-08-01
Trial Details
NCT Number NCT05169333
Lead Sponsor University of Oxford
Collaborators: Caristo Diagnostics Limited, Oxford University Hospitals NHS Trust, British Heart Foundation, Innovate UK, European Commission
Conditions Cardiovascular Diseases, Cardiovascular Risk Factors
Enrollment 250,000 participants
Start Date 2016-02-23
Primary Completion 2030-02 (estimated)
Study Completion 2030-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-31